New NHS plan will ‘fundamentally rewire' health service
Sir Keir Starmer will use a speech in London on Thursday to unveil his vision for the NHS, which will focus on 'three big shifts' in the way the health service operates.
The new plan, which will be published by the Government on Thursday, sets out how the NHS will move from analogue to digital, treatment to prevention, and from hospital to more community care.
The 'status quo of hospital by default will end', according to the Government, with care shifted into neighbourhoods and people's homes.
By 2035, the intention is that the majority of outpatient care will happen outside of hospitals, with less need for hospital-based appointments for things like eye care, cardiology, respiratory medicine and mental health.
New neighbourhood health services will be rolled out across the country to bring tests, post-op care, nursing and mental health teams closer to people's homes.
The aim is to give people access to a full range of services, leaving hospitals to focus on the sickest, with neighbourhood health centres opening at evenings and weekends.
These will be staffed by teams including nurses, doctors, social care workers, pharmacists, health visitors, palliative care staff and paramedics.
New services will also include debt advice, employment support and stop smoking or obesity services – all of which affect people's health.
Community outreach, with people going door to door, could also reduce pressure on GPs and A&E, the Government said.
The plans also outline training for thousands more GPs, as the Government pledges to 'bring back the family doctor' and end the '8am scramble' to get an appointment.
Sir Keir said: 'The NHS should be there for everyone, whenever they need it.
'But we inherited a health system in crisis, addicted to a sticking plaster approach, and unable to face up to the challenges we face now, let alone in the future.
'That ends now. Because it's reform or die. Our 10-year health plan will fundamentally rewire and future-proof our NHS so that it puts care on people's doorsteps, harnesses game-changing tech and prevents illness in the first place.
'That means giving everyone access to GPs, nurses and wider support all under one roof in their neighbourhood – rebalancing our health system so that it fits around patients' lives, not the other way round.
'This is not an overnight fix, but our Plan for Change is already turning the tide on years of decline with over four million extra appointments, 1,900 more GPs, and waiting lists at their lowest level for two years.
'But there's more to come. This Government is giving patients easier, quicker and more convenient care, wherever they live.'
Health and Social Care Secretary Wes Streeting said the plan would deliver 'one of the most fundamental changes in the way we receive our healthcare in history'.
He added: 'By shifting from hospital to community, we will finally bring down devastating hospital waiting lists and stop patients going from pillar to post to get treated.
'This Government's Plan for Change is creating an NHS truly fit for the future, keeping patients healthy and out of hospital, with care closer to home and in the home.'
In a bid to free up time, GPs will be encouraged to use artificial intelligence to take notes, while technology will be used to speed up the answering of calls to surgeries.
Dental therapists, who tend to carry out some of the straightforward work of dentists, could undertake check-ups, treatment and referrals, according to the plan.
And there will be a new requirement for newly-qualified dentists to practise in the NHS for a minimum period, intended to be three years, according to the Government.
Ministers also want to improve access to dental care for children, such as by allowing dental nurses to give fluoride varnish to children in between check-ups.
Royal College of Nursing (RCN) general secretary, Professor Nicola Ranger, said: ''A neighbourhood health service is a bold vision and it needs nursing staff in the driving seat.
'The Prime Minister must back up his plan with a clear one to turn around the shortage of nurses in all local communities.
'Moving care away from overcrowded hospitals is urgent and necessary but it will prove impossible whilst this part of the healthcare workforce is so depleted and undervalued.
'Crucial teams of district nursing and health visiting staff, who keep patients well and safe at home, have fallen by thousands in the last decade or more.'
Thea Stein, chief executive of the Nuffield Trust, said: 'Top quality community services, like district nursing, end of life care and rehabilitation, are, in pockets of the country, already working around the clock to fit care around patients' needs, working closely with GPs, charities and council staff.
'This approach is essential if we want to end the disjointed ways of working that too often leave patients to do the time-consuming and often bewildering job of joining up their own care.'
She said, however, that a lack of detail on how it will all work 'casts doubt on whether it will stick'.
She added: 'What's more, care closer to home doesn't mean care on the cheap.
'While ministers are always keen to cite examples of community services saving money, often this kind of care costs more, not less… let's be under no illusion, this is not a money-saving measure.'
Sarah Woolnough, chief executive of the King's Fund, said: 'As the Government publishes its 10-year plan for health today, what patients, the public and those working in the NHS will want to know is, why it will be different this time, and how soon it will lead to improvements?
'When will it mean people can see a GP more easily, or get mental health support for their child, or not wait hours in A&E?
'There is plenty to welcome in the details we've seen so far, with the biggest changes outlined being about how people access NHS services, with the rollout of new neighbourhood health centres and a much greater role for the NHS app.
'At the King's Fund our call for a fundamental shift of care from hospital to community and a more people-first approach has been echoed by successive governments, so, whilst welcome, the vision itself is not new, the radical change would be delivering the vision.'
The Government's political opponents were sceptical about the plan, with Conservative shadow health secretary Edward Argar insisting that it must provide reform and 'that reform must be real, it needs to be deliverable, and crucially it must deliver results for patients'.
He added: 'But after the collapse of their Welfare Bill, the government's tough talk seems meaningless. This Government has proven they cannot stand up to their own MPs or take tough decisions in the national interest.'
Liberal Democrat Leader Sir Ed Davey said the plan 'will be a castle built on sand until ministers finally tackle the crisis in social care'.
He added: 'Years of Conservative neglect pushed the NHS to breaking point, with overcrowded A&Es, people waiting weeks to see a GP and parents unable to find a dentist for their children.
'But the current Government's failure to fix social care is leading to more of the same, as vulnerable people are stuck in hospital beds while their families are left in anguish.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
34 minutes ago
- Medscape
Brain Changes Linked to Dementia Found in Ex-Rugby Players
Two studies led by researchers at Imperial College London (ICL) have identified structural brain changes and blood biomarkers linked to dementia in former professional rugby players. The findings provide the first prospective evidence of physical brain and blood abnormalities in this group. Previous research had already shown that elite rugby players face a higher risk of neurodegenerative diseases later in life. The studies examined links between repeated head impacts in rugby and conditions such as Alzheimer's disease and chronic traumatic encephalopathy (CTE). Post-mortem examinations of former players have shown neuropathologies consistent with repetitive brain trauma. Traumatic brain injury, already a known risk factor for neurodegeneration, contributes to an estimated 3%-15% of dementia cases in the general population. While recent advances in fluid and imaging biomarkers have transformed dementia diagnosis, these techniques have not been systematically applied to rugby players previously exposed to multiple head impacts. Study Cohort and Methods The research involved 200 ex-professional rugby players aged 30-61 (median age, 44), all of whom had self-referred with brain health concerns but had no dementia diagnosis at baseline. At least one previous concussion while playing was reported by 193 (96.5%) of the former players, with a median of seven concussions. The rugby group was compared with 33 age- and sex-matched healthy controls with no evidence of previous head trauma or dementia onset. Participants were 90% male. The median rugby career lasted 10.5 years, with 63% playing as forwards and 37% as backs. Mental Health and Behavioural Symptoms The former players scored higher on self-rated scales of depression, anxiety, and post-concussion symptoms than those in the control group, though not on sleep quality. These symptoms, along with behaviour ratings of executive dysfunction and neuropsychiatric symptom severity, were more prevalent among individuals who had experienced a greater number of self-reported concussions. However, this was unrelated to the number of years played, or position of play. Despite frequent subjective memory complaints, the performance of players in cognitive testing did not differ significantly from that of the control group. However, 24 former players, particularly those who had played as forwards and those who had reported more concussions, met the research criteria for CTE syndrome based on neurobehavioural disturbance. This was determined with low provisional levels of certainty: 21 were classed as 'suggestive.' three as 'possible.' and none as 'probable/definite.' Seven of the 24 had cognitive impairment, 12 had neurobehavioral dysregulation, and five had both. Imaging Findings 3T MRI imaging showed the presence of cavum septum pellucidum in 24% of players, compared with 12% of controls. This was more common in those who had experienced more concussions. They also showed reduced volumes in the frontal and cingulate cortices, with reduced white matter and lower hippocampal volume associated with longer career durations. Only 4.6% showed trauma-associated white matter changes on diffusion tensor imaging. Elevated Blood Biomarkers Using ultrasensitive digital enzyme-linked immunosorbent assays, researchers analysed fluid biomarkers associated with neurodegeneration. Key findings included: Phospho-tau217 levels were 17.6% higher in former players 23.1% had elevated phospho-tau217 9.0% had raised plasma neurofilament light While levels were lower than in late-onset Alzheimer's patients, players with elevated markers had more severe neuropsychiatric symptoms, including depression and anxiety. Frontal brain volumes correlated negatively with neurofilament light, and hippocampal volumes correlated negatively with phospho-tau217. The findings were published simultaneously in two papers in the journal Brain . Professor David Sharp, director of the UK Dementia Research Institute Centre for Care Research & Technology at ICL, who co-led the work, said: 'We didn't see any cases of early dementia in this group of former players, which is reassuring. However, the changes in blood biomarkers and brain imaging abnormalities show some long-term effects of repeated head impacts on the brain.' The studies are set to continue for a further 4 years. Calls for Action on Player Safety 'Nearly half of dementia cases are linked to known health and lifestyle risk factors, including traumatic brain injury from contact sports like rugby,' said Dr Jacqui Hanley, head of research at Alzheimer's Research UK. While not much is known about how such injuries cause changes to the brain, 'deepening our understanding could ultimately help lower dementia risk for professional sportspeople.' Hanley called for stronger efforts to reduce head injury in contact sports, stating: 'Reducing traumatic brain injury in contact sports is critical to help prevent brain damage and minimise dementia risk for the players.' The Alzheimer's Society echoed the concern, noting that professional rugby players face approximately twice the risk of dementia. They called for accurate data on injury patterns and their long-term effects. However, they also stressed that physical activity remains one of the most effective ways to reduce dementia risk. The Dementia Trust has warned that repeated tackles, scrums, and collisions can contribute to CTE among rugby players and noted a rise in early-onset dementia among retired professional players. In 2023, a group of 260 former professionals launched a lawsuit against World Rugby, the Welsh Rugby Union, and the Rugby Football Union. They alleged negligence in failing to protect players from the risk of neurodegenerative diseases.
Yahoo
41 minutes ago
- Yahoo
UK Government reveals 10-year plan for NHS
The UK's Labour Government has revealed its '10-Year Health Plan' for the country's National Health Service (NHS). Speaking at a community health centre in London, Health Secretary Wes Streeting outlined what the plan encompasses. This includes a shift from the NHS being a 'sick service' to one that is preventative – an approach Prime Minister Sir Kier Starmer, who also appeared at the launch in Stratford, said will be achieved with a stronger focus on early diagnosis and screening with the use of technology such as AI. The plan's release follows Chancellor of the Exchequer Rachel Reeves' announcement last month that the NHS is set to receive a £29bn funding boost over the next three years. With £10bn ($13.5bn) of the total NHS funding Reeves announced to be earmarked to bring the 'analogue health system into the digital age', another key shift outlined by Starmer lies in transforming the NHS from an analogue to a 'truly digital' service. A report co-authored by Boston Consulting Group (BCG), Siemens Healthineers, and Imperial College London that was commissioned by the NHS as input to its ten-year plan, forecasts that technology-driven innovation, with a focus on earlier diagnosis, has the potential to impact population outcomes through risk stratification and intervention to 'prevent disease and alleviate burden on the broader healthcare system'. Starmer emphasised that the NHS must seize the 'enormous opportunities' presented by developments in science and technology. The UK Prime Minister said: 'AI technology is an opportunity to make us more human,' clarifying that the introduction of more technology within the NHS would give NHS staff more time to 'do the things that only human beings can do'. Regarding technology, he added that there was 'no reason' the future of the NHS could not be a more app-based service, with greater application of the service's app planned for securing appointments and giving patients easier access to participation in clinical trials. Plans would shift the NHS towards being more of a community service, with the introduction of new community health centres. Calling such venues the 'future of the health service', Starmer said: 'Hospitals will always be important, but disease has changed, and we must change with it. Not only can we do that, we can do it in a way that improves care and convenience for millions of people.' According to the Prime Minister, this shift will help improve patient access to general practitioners (GPs), dentists and other services, including mental health support and smoking cessation clinics in 'every community across the country'. Clive Makombera, partner and head of NHS at RSM UK, an audit, tax, and consulting company, called the 10-Year Plan a 'pivotal moment for the future of the NHS'. He said: 'By embedding digital innovation, shifting care closer to home, and focusing on prevention, the NHS is laying the foundation for a more sustainable, equitable, and patient-centred future. 'Whilst these are the right priorities, delivering them will come with their challenges, even with the new funding that was recently announced.' Makombera cautioned that in achieving the government's aims, it must 'get the basics right' and rebalance resources and funding within the NHS to match its priorities. He continued: 'Shifting from reactive treatment to prevention will only be achievable by making better use of technology, delivering care closer to home and developing new models that centre around accountability. However, the NHS desperately needs more staff with the right skill set, which might require leveraging the expertise of the private healthcare sector. That said, existing workforce shortages in the healthcare system cannot be underestimated.' British Healthcare Trades Association (BHTA) CEO David Stockdale said the BHTA welcomed the plan's shift to community-centric care. "But at its foundation must lie the manufacturers and suppliers of essential medical equipment who enable independent living and timely hospital discharges," Stockdale said. "Without them, this vision simply won't take hold." BMA council chair Dr Tom Dolphin highlighted that the plan must show that the Government 'truly values' clinical leaders in the NHS. Dolphin said: 'The success of the plan, and whether it will improve patients' care and the public's lives, will hinge on whether it genuinely addresses the workforce shortages, and values and empowers professionals on the front line, or just rearranges deck chairs on a sinking ship. 'If this plan is to be as ambitious and transformative as the government would have us believe, it needs the backing of staff and any changes must be implemented in genuine partnership with workers on the frontline.' Association of the British Pharmaceutical Industry (ABPI) CEO Richard Torbett called the plans to boost the NHS's offer on genomic medicine and accelerate clinical trials 'exactly right and very welcome'. 'This will transform patients' lives and take better advantage of the precision medicines and benefits of research that our sector can offer,' Torbett said. 'However, the successful implementation of the NHS 10-Year Plan will require a fundamental shift in how the UK approaches innovative medicines and vaccines. For too long, the UK has viewed innovation as a cost to be avoided, rather than an investment that can improve health outcomes and system productivity. 'The UK must reverse decades of disinvestment in innovative medicines that is increasingly preventing NHS patients from accessing medicines that are available in other countries.' Gerard Hanratty, head of health and life sciences at law company Browne Jacobson, held the banking industry up as one the NHS should take cues from. He said: 'Healthcare can learn much from the banking industry's digital transformation journey, which has been underpinned by consumer acceptance – and enthusiasm – for sharing sensitive data that provides real-time metrics and intelligent insights to manage finances effortlessly. 'Replicating this model to create 'digital health wallets' – secure, user-controlled platforms for storing, managing and sharing health information – could revolutionise patient self-management and open the door to incentivisation initiatives that are fundamental to the move from sickness care to prevention.' Amadeus Capital Partners' Pierre Socha called the NHS' plans to expand access to clinical trials through the NHS app a 'welcome step toward a more predictive, personalised healthcare system'. He commented: 'We've long believed that AI-driven diagnostics are foundational to the future of medicine. By embedding these technologies into national infrastructure, the UK is not only improving patient outcomes but also reinforcing its position as a global leader in life sciences innovation. "The integration of genomic data into routine care, combined with streamlined access to clinical trials via the NHS App, has the potential to accelerate drug development, reduce health inequalities, and unlock new models of preventative care.' "UK Government reveals 10-year plan for NHS" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
2 hours ago
- Bloomberg
Summit Is in Talks for $15 Billion Partnership With AstraZeneca
By and Dinesh Nair Save AstraZeneca Plc is discussing a partnership deal with Summit Therapeutics Inc. in which it could pay as much as $15 billion over time to license a lung-cancer drug, according to people familiar with the matter. The companies have been holdings talks regarding the potential partnership over Summit's ivonescimab treatment, the people said, asking not to be identified because that matter is private. Summit has also held discussions with other major pharmaceutical firms, the people said.
